$XLO 3 SEC Filings

Filed On	Filing
02 Oct 2026	Form 3: Houvras Yariv, CHIEF MEDICAL OFFICER No securities owned
16 Apr 2026	Form 3: Blanchard Cheryl R, Director No securities owned
12 Jun 2025	Form 3: Bello Akintunde Olatokumbo, Director No securities owned
27 Sep 2024	Form 3: Chudnovsky Yekaterina, 10% owner and 1 other Holds 7,000,000 shares of Common Stock
17 Jun 2024	Form 3: Shannon James Samuel, Director No securities owned
17 Jun 2024	Form 3: Brennan Aoife, Director No securities owned
03 Apr 2024	Form 3: Gilead SCIENCES, Inc., 10% owner Holds 6,860,223 shares of Common Stock
07 Sep 2023	Form 3: Luptakova Katarina, Chief Medical Officer
07 Aug 2023	Form 3: Frankenfield Christopher James, Chief Operating Officer
03 Apr 2023	Form 3: Brennan Kevin M., SVP, FINANCE AND ACCOUNTING No securities owned
16 Nov 2022	Form 3: English Edward C, Principal Accounting Officer Holds 6,002 shares of Common Stock
16 Sep 2022	Form 3: Heyman Tomas J., Director No securities owned
17 Jun 2022	Form 3: Ross Robert W., Director No securities owned
06 Jan 2022	Form 3: Xu Yuan, Director No securities owned
05 Nov 2021	Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 5 others Holds 2,762,944 shares of Common Stock
22 Oct 2021	Form 3: Williams John Charles, 10% owner Holds 100,080 shares of Common Stock
21 Oct 2021	Form 3: Flynn James E, 10% owner and 4 others
21 Oct 2021	Form 3: Fil Ltd, 10% owner
21 Oct 2021	Form 3: Alexandria Venture Investments, Llc, 10% owner
21 Oct 2021	Form 3: Estate of Ulrich Rodeck, 10% owner Holds 100,080 shares of Common Stock

Comments